Abstract
Coeliac sprue is traditionally perceived as a disease related to early age, although young individuals may also suffer from typical bowel symptoms, which belong to the group of active coeliac syndromes. This opinion has been so far generally accepted by the medical public. Full-scale screening performed in the European countries and in the USA, however, has shown that the prevalence of this condition is about 1:100. It means that there are about 40,000–50,000 people affected by coeliac sprue in the Czech Republic, although currently the diagnosis has been established only in 15–20 % of the patients and the greater part of them remains undiagnosed. Thus, a majority of patients affected by coeliac disease are asymptomatic, oligosymptomatic, i.e. without typical intestinal symptoms of coeliac disease, and are therefore included in the category of atypical and silent coeliac disease (Table 21.1). This group comprises most adults without diagnosed coeliac disease. The most frequent atypical manifestation of the disease in adults and in the elderly is osteoporosis which, when combined in women with postmenopausal osteoporosis, may be difficult to treat. Therefore, attention should be paid to elderly patients with osteoporosis, where the incidence of coeliac disease may be expected in at least 3–6 % of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Thomson A, et al. WGO-OMEG Practice guideline, osteoporosis and gastrointestinal diseases. 2004. www.omge.org/globalguidelines.htm.
Dewar D, Ciclitira P. Clinical features and diagnosis of celiac disease. Gastroenterology. 2005;128 Suppl 1:S19–24.
Bernstein C, Leslie W, et al. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:795–841.
Bischoff S, Crowe S. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology. 2005;128:1–36.
Samson HA, Sichere SH. AGA technical review on the evaluation of food allergy in gastrointestinal disorders. Gastroenterology. 2001;120:1026–40.
Lewis N, Sčoty B. Guidelines for osteoporosis in inflammatory bowel disease and coeliac disease. BSG Gudilines in Gastroenterology. 2007. www.bsg.org.uk.
Štěpan J, Hana V. Osteoporosa u mužů; Diabetologie, metabolismus, endokrinologie, výživa. 2006;9(Suppl 1):46–55. [In Czech].
Bernstein C, Leslie W. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:791–4.
Di Stefano M. Lactose malabsorption and intolerance and peak bone mass. Gastroenterology. 2002;122:1793–9.
WGO-OMGE Practise Guideline: Malabsorption. www.omge.org/globalguidelines.html.
Leslie W, Bernstein C. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology. 2003;125(3):1–41.
Leslie W, Bernstein C. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology. 2006;130(3):935–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Fojtík, P., Kliment, M., Novosad, P. (2017). Coeliac Disease in Elderly Patients. In: Rovenský, J. (eds) Gerontorheumatology. Springer, Cham. https://doi.org/10.1007/978-3-319-31169-2_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-31169-2_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31167-8
Online ISBN: 978-3-319-31169-2
eBook Packages: MedicineMedicine (R0)